155 related articles for article (PubMed ID: 17582660)
1. Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.
Goeminne A; McNaughton M; Bal G; Surpateanu G; Van Der Veken P; De Prol S; Versées W; Steyaert J; Haemers A; Augustyns K
Eur J Med Chem; 2008 Feb; 43(2):315-26. PubMed ID: 17582660
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of bicyclic N-arylmethyl-substituted iminoribitol derivatives as selective nucleoside hydrolase inhibitors.
Berg M; Bal G; Goeminne A; Van der Veken P; Versées W; Steyaert J; Haemers A; Augustyns K
ChemMedChem; 2009 Feb; 4(2):249-60. PubMed ID: 19115304
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax.
Versées W; Decanniere K; Pellé R; Depoorter J; Brosens E; Parkin DW; Steyaert J
J Mol Biol; 2001 Apr; 307(5):1363-79. PubMed ID: 11292348
[TBL] [Abstract][Full Text] [Related]
4. N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase.
Goeminne A; Berg M; McNaughton M; Bal G; Surpateanu G; Van der Veken P; De Prol S; Versées W; Steyaert J; Haemers A; Augustyns K
Bioorg Med Chem; 2008 Jul; 16(14):6752-63. PubMed ID: 18571422
[TBL] [Abstract][Full Text] [Related]
5. Transition-state complex of the purine-specific nucleoside hydrolase of T. vivax: enzyme conformational changes and implications for catalysis.
Versées W; Barlow J; Steyaert J
J Mol Biol; 2006 Jun; 359(2):331-46. PubMed ID: 16630632
[TBL] [Abstract][Full Text] [Related]
6. 1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors.
Goeminne A; McNaughton M; Bal G; Surpateanu G; Van der Veken P; De Prol S; Versées W; Steyaert J; Apers S; Haemers A; Augustyns K
Bioorg Med Chem Lett; 2007 May; 17(9):2523-6. PubMed ID: 17317181
[TBL] [Abstract][Full Text] [Related]
7. Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases.
Parkin DW; Limberg G; Tyler PC; Furneaux RH; Chen XY; Schramm VL
Biochemistry; 1997 Mar; 36(12):3528-34. PubMed ID: 9132003
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of T. vivax nucleoside hydrolase in complex with new potent and specific inhibitors.
Versées W; Goeminne A; Berg M; Vandemeulebroucke A; Haemers A; Augustyns K; Steyaert J
Biochim Biophys Acta; 2009 Jun; 1794(6):953-60. PubMed ID: 19281874
[TBL] [Abstract][Full Text] [Related]
9. Pre-steady-state analysis of the nucleoside hydrolase of Trypanosoma vivax. Evidence for half-of-the-sites reactivity and rate-limiting product release.
Vandemeulebroucke A; Versées W; De Vos S; Van Holsbeke E; Steyaert J
Biochemistry; 2003 Nov; 42(44):12902-8. PubMed ID: 14596604
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis.
Berg M; Kohl L; Van der Veken P; Joossens J; Al-Salabi MI; Castagna V; Giannese F; Cos P; Versées W; Steyaert J; Grellier P; Haemers A; Degano M; Maes L; de Koning HP; Augustyns K
Antimicrob Agents Chemother; 2010 May; 54(5):1900-8. PubMed ID: 20194690
[TBL] [Abstract][Full Text] [Related]
11. Computational study of IAG-nucleoside hydrolase: determination of the preferred ground state conformation and the role of active site residues.
Mazumder-Shivakumar D; Bruice TC
Biochemistry; 2005 May; 44(21):7805-17. PubMed ID: 15909995
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-substrate interactions in the purine-specific nucleoside hydrolase from Trypanosoma vivax.
Versées W; Decanniere K; Van Holsbeke E; Devroede N; Steyaert J
J Biol Chem; 2002 May; 277(18):15938-46. PubMed ID: 11854281
[TBL] [Abstract][Full Text] [Related]
13. QM/MM molecular dynamics study of purine-specific nucleoside hydrolase.
Wu R; Gong W; Liu T; Zhang Y; Cao Z
J Phys Chem B; 2012 Feb; 116(6):1984-91. PubMed ID: 22257300
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization and homology modeling of a purine-specific ribonucleoside hydrolase from the archaeon Sulfolobus solfataricus: insights into mechanisms of protein stabilization.
Porcelli M; Peluso I; Marabotti A; Facchiano A; Cacciapuoti G
Arch Biochem Biophys; 2009 Mar; 483(1):55-65. PubMed ID: 19121283
[TBL] [Abstract][Full Text] [Related]
15. Leaving group activation by aromatic stacking: an alternative to general acid catalysis.
Versées W; Loverix S; Vandemeulebroucke A; Geerlings P; Steyaert J
J Mol Biol; 2004 Apr; 338(1):1-6. PubMed ID: 15050818
[TBL] [Abstract][Full Text] [Related]
16. Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis.
Guimarães AP; Oliveira AA; da Cunha EF; Ramalho TC; França TC
J Biomol Struct Dyn; 2011 Feb; 28(4):455-69. PubMed ID: 21142217
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.
Li L; Chang L; Pellet-Rostaing S; Liger F; Lemaire M; Buchet R; Wu Y
Bioorg Med Chem; 2009 Oct; 17(20):7290-300. PubMed ID: 19781951
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases.
Vassiliou S; Grabowiecka A; Kosikowska P; Yiotakis A; Kafarski P; Berlicki Ł
J Med Chem; 2008 Sep; 51(18):5736-44. PubMed ID: 18717581
[TBL] [Abstract][Full Text] [Related]
19. Iminoribitol transition state analogue inhibitors of protozoan nucleoside hydrolases.
Miles RW; Tyler PC; Evans GB; Furneaux RH; Parkin DW; Schramm VL
Biochemistry; 1999 Oct; 38(40):13147-54. PubMed ID: 10529186
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors.
Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
Bioorg Med Chem; 2007 Apr; 15(7):2749-58. PubMed ID: 17287121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
